| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
Hamilton Christine E serves as a Director, 10% Owner at SABS and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $3.7M at current prices.
The biggest single holding is SABS (~$3.7M) as Director, 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 10,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2022 | SABS Sab Biotherapeutics, Inc. | Director, 10% Owner | Buy | 10,000 | $0.73 | $7,297.00 | +0.2% | +35.2% | -15.3% |